FDA Adverse Event Death Summary report: N

NUVASIVENVM5 SYSTEM

MDR report key: 6594233 · Received May 26, 2017

Report

Report Number
2031966-2017-00054
Event Type
Death
Date Received
May 26, 2017
Date of Event
April 25, 2017
Report Date
May 25, 2017
Manufacturer
NUVASIVE, INC.
Product Code
PDQ
PMA / PMN Number
K152942
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

NO PRODUCT RETURNED FOR EVALUATION. LITERATURE REVIEW: "CONTRAINDICATIONS, THE NVM5® SYSTEM MAY NOT BE EFFECTIVE, AND IS NOT INTENDED FOR USE, WHEN NEUROMUSCULAR BLOCK OR EPIDURAL BLOCKS HAVE BEEN USED FOR, OR IN CONJUNCTION WITH, ANESTHESIA. CONTRAINDICATIONS TO USE OF TRANSCRANIAL MOTOR EVOKED POTENTIAL (MEP) MONITORING INCLUDE EPILEPSY, CORTICAL LESIONS, CONVEXITY SKULL DEFECTS, RAISED INTRACRANIAL PRESSURE, CARDIAC DISEASE, PRO-CONVULSANT MEDICATIONS OR ANESTHETICS, INTRACRANIAL ELECTRODES, VASCULAR CLIPS OR SHUNTS, AND CARDIAC PACEMAKERS OR OTHER IMPLANTED BIOMEDICAL DEVICES. OTHERWISE UNEXPLAINED INTRAOPERATIVE SEIZURES AND POSSIBLY ARRHYTHMIAS ARE INDICATIONS TO ABORT MEP." "CONTRAINDICATION: DO NOT USE CUTANEOUS ELECTRODES FOR STIMULATION (STIMULATION ELECTRODES) IF THE PATIENT HAS A CARDIAC PACEMAKER, IMPLANTED DEFIBRILLATOR, OR OTHER IMPLANTED METALLIC OR ELECTRONIC DEVICE. SUCH USE COULD CAUSE ELECTRIC SHOCK, BURNS, ELECTRICAL INTERFERENCE, OR DEATH." "WARNING: PATIENTS WITH IMPLANTED ELECTRONIC DEVICES, SUCH AS CARDIAC PACEMAKERS, SHOULD NOT BE SUBJECTED TO ELECTRICAL STIMULATION UNLESS SPECIALIST MEDICAL OPINION HAS FIRST BEEN OBTAINED."

Description of Event or Problem · 1

RECEIVED INFORMATION STATING THAT ON (B)(6)2017, PATIENT UNDERWENT A DISCECTOMY INFUSION WITH POSTERIOR FIXATION REPORTEDLY WITH NO COMPLICATIONS. AS PER REPORTER PATIENT EXPIRED THAT NIGHT DUE TO ACUTE MYOCARDIAL INFARCTION. NO ALLEGATION OF PRODUCT MALFUNCTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
375997 NUVASIVENVM5 SYSTEM NEUROSURGICAL NERVE LOCATOR PDQ NUVASIVE, INC. NVM5

Patients

Seq Age Sex Outcome Treatment
1 Death